Company Details
- Employees
- 77
- Founded
- -
- Address
- Mountain View, California 94041, Us
- in****@****nce.com
- Industry
- Biotechnology
- Website
- altoneuroscience.com
- Keywords
- (AWS).
- HQ
- Mountain View, California
Please complete the CAPTCHA to continue
Related company profiles:
Alto Neuroscience to Participate in Upcoming Investor Conferences Yahoo Finance
Alto Neuroscience Announces Plans to Accelerate Development of ALTO-207 in Treatment Resistant Depression Following Successful Outcome from Recent FDA Meeting Yahoo Finance
Alto Neuroscience Reports Second Quarter 2025 Financial Results and Recent Business Highlights Yahoo Finance
Alto Neuroscience Receives FDA Fast Track Designation for ALTO-101 for the Treatment of Cognitive Impairment Associated with Schizophrenia Business Wire
Alto Neuroscience Announces Robust Replication of EEG Biomarker to Objectively Identify Patients with Cognitive Impairment in Schizophrenia Yahoo Finance
Alto Neuroscience Highlights Peer-Reviewed Publication of PAX-D Study in The Lancet Psychiatry Demonstrating Robust Clinical Effects of Pramipexole for Patients with Treatment-Resistant Depression Yahoo Finance
Alto Neuroscience Appoints Biotech Industry Veteran, Raymond Sanchez, M.D., to Its Board of Directors Business Wire
Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway Yahoo Finance
Alto Neuroscience Announces U.S. Patent Granted Covering ALTO-300 as a Treatment for Patients with Major Depressive Disorder Characterized by an Electroencephalogram Biomarker Yahoo Finance
Alto Neuroscience to Participate in Upcoming Investor Conferences Business Wire
Alto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203 Business Wire
Alto Neuroscience Reports Full-Year 2024 Financial Results and Recent Business Highlights Business Wire
Alto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business Highlights Business Wire
Alto Neuroscience Announces Favorable Outcome from Interim Analysis of ALTO-300 Phase 2b Major Depressive Disorder Trial Business Wire
Alto Neuroscience Advances Four Phase 2 Trials With Precision Psychiatry Focus Psychiatric Times
Alto Neuroscience Reports Third Quarter 2024 Financial Results and Recent Business Highlights Yahoo Finance
Alto Neuroscience Announces Pricing of Upsized Initial Public Offering Business Wire
Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia Business Wire
User FinancialContent
Alto Neuroscience Announces $60 Million in Additional Financing Business Wire
Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry Business Wire
Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing GlobeNewswire
1 +191964XXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.